Effect of pippermint on nausea in pediatrics with leukemia undergoing chemotherapy

Phase 3

Recruiting

• Conditions: ausea, vomiting and Anorexia.; Nausea and vomiting

• Registration Number: IRCT20171203037733N4
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

Written conset to participate in the study
Definitive diagnosis of myeloid leukemia and acute lymphocytic (ALL and AML) by a pediatric hematologist and oncologist (other than None M3ALL )
Receiving chemotherapy courses
History of receiving at least one course of chemotherapy
Experience of nausea following previous chemotherapy sessions
No concomitant radiotherapy with chemotherapy
Age 3 to 18 years

Exclusion Criteria

Using medications or other treatments to reduce nausea other than the usual prescribed anti-nausea and vomiting medications (especially herbal remedies)
Nausea and vomiting resistant to treatment
Unwillingness to participating in the study
sensitivity to mint
other nausea problems such as hypertention , liver failure , kidney and digestive problems

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ausea. Timepoint: Before, immediately, 24 hours, 48 hours after chemotherapy. Method of measurement: VAS questionnaire and measurement table and Face scale.;Vomiting. Timepoint: Before, immediately, 24 hours, 48 hours after chemotherapy. Method of measurement: VAS questionnaire and measurement table and Face scale.;Anorexia. Timepoint: Before, immediately, 24 hours, 48 hours after chemotherapy. Method of measurement: VAS questionnaire and measurement table and Face scale.